BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37031346)

  • 1. Proton boron capture therapy (PBCT) induces cell death and mitophagy in a heterotopic glioblastoma model.
    Cammarata FP; Torrisi F; Vicario N; Bravatà V; Stefano A; Salvatorelli L; D'Aprile S; Giustetto P; Forte GI; Minafra L; Calvaruso M; Richiusa S; Cirrone GAP; Petringa G; Broggi G; Cosentino S; Scopelliti F; Magro G; Porro D; Libra M; Ippolito M; Russo G; Parenti R; Cuttone G
    Commun Biol; 2023 Apr; 6(1):388. PubMed ID: 37031346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Radioresponse and Radiosensitizers in Glioblastoma Organotypic Cultures.
    Bayin NS; Ma L; Placantonakis DG; Barcellos-Hoff MH
    Methods Mol Biol; 2018; 1741():171-182. PubMed ID: 29392699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Proton-Boron Reaction Increases the Radiobiological Effectiveness of Clinical Low- and High-Energy Proton Beams: Novel Experimental Evidence and Perspectives.
    Bláha P; Feoli C; Agosteo S; Calvaruso M; Cammarata FP; Catalano R; Ciocca M; Cirrone GAP; Conte V; Cuttone G; Facoetti A; Forte GI; Giuffrida L; Magro G; Margarone D; Minafra L; Petringa G; Pucci G; Ricciardi V; Rosa E; Russo G; Manti L
    Front Oncol; 2021; 11():682647. PubMed ID: 34262867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Proton-Induced DNA Damage in 3D-Engineered Glioblastoma Microenvironments.
    Akolawala Q; Rovituso M; Versteeg HH; Rondon AMR; Accardo A
    ACS Appl Mater Interfaces; 2022 May; 14(18):20778-20789. PubMed ID: 35442634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental validation of proton boron capture therapy for glioma cells.
    Shtam T; Burdakov V; Garina A; Garaeva L; Tran NH; Volnitskiy A; Kuus E; Amerkanov D; Pack F; Andreev G; Lubinskiy A; Shabalin K; Verlov N; Ivanov E; Ezhov V; Lebedev D; Konevega AL
    Sci Rep; 2023 Jan; 13(1):1341. PubMed ID: 36693879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
    Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses.
    Gomez-Roman N; Stevenson K; Gilmour L; Hamilton G; Chalmers AJ
    Neuro Oncol; 2017 Feb; 19(2):229-241. PubMed ID: 27576873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
    Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
    Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
    [No Abstract]   [Full Text] [Related]  

  • 9. Duocarmycin SA, a potent antitumor antibiotic, sensitizes glioblastoma cells to proton radiation.
    Boyle KE; Boger DL; Wroe A; Vazquez M
    Bioorg Med Chem Lett; 2018 Sep; 28(16):2688-2692. PubMed ID: 29650288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
    Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
    Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib enhances radiosensitivity of hypoxic glioblastoma cells through endoplasmic reticulum stress.
    Suzuki K; Gerelchuluun A; Hong Z; Sun L; Zenkoh J; Moritake T; Tsuboi K
    Neuro Oncol; 2013 Sep; 15(9):1186-99. PubMed ID: 23658321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere targeting with a new G4 ligand enhances radiation-induced killing of human glioblastoma cells.
    Merle P; Evrard B; Petitjean A; Lehn JM; Teulade-Fichou MP; Chautard E; De Cian A; Guittat L; Tran PL; Mergny JL; Verrelle P; Tchirkov A
    Mol Cancer Ther; 2011 Oct; 10(10):1784-95. PubMed ID: 21987532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current State and Prospectives for Proton Boron Capture Therapy.
    Tran NH; Shtam T; Marchenko YY; Konevega AL; Lebedev D
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study.
    Stegen B; Nieto A; Albrecht V; Maas J; Orth M; Neumaier K; Reinhardt S; Weick-Kleemann M; Goetz W; Reinhart M; Parodi K; Belka C; Niyazi M; Lauber K
    Radiat Oncol; 2020 Jan; 15(1):19. PubMed ID: 31969174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation.
    Pezuk JA; Brassesco MS; Morales AG; de Oliveira JC; de Oliveira HF; Scrideli CA; Tone LG
    Cancer Biother Radiopharm; 2013 Sep; 28(7):516-22. PubMed ID: 23713868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.
    Hardee ME; Marciscano AE; Medina-Ramirez CM; Zagzag D; Narayana A; Lonning SM; Barcellos-Hoff MH
    Cancer Res; 2012 Aug; 72(16):4119-29. PubMed ID: 22693253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma.
    Haselsberger K; Radner H; Pendl G
    Neurosurgery; 1996 Aug; 39(2):321-5; discussion 325-6. PubMed ID: 8832669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmortem neuropathological features secondary to boron neutron capture therapy for glioblastoma multiforme.
    Aziz T; Peress NS; Diaz A; Capala J; Chanana A
    J Neuropathol Exp Neurol; 2000 Jan; 59(1):62-73. PubMed ID: 10744036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermia enhances thermal-neutron-induced cell death of human glioblastoma cell lines at low concentrations of 10B.
    Kinashi Y; Masunaga SI; Suzuki M; Ono K; Ohnishi T
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1185-92. PubMed ID: 9539576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.